Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesClever Leaves Holdings Inc

Clever Leaves Holdings Inc

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.001 USD 0.00(0%)
Last update at 2026-11-05T21:00:00Z
VOLUME
25267
Market Cap
0.00M

Momentum Score

…

Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
-
Low
0.03
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Clever Leaves Holdings is an international medical-cannabis company that cultivates, manufactures and distributes pharmaceutical-grade cannabis and extracts from facilities in Latin America and Europe. Long-term growth may be supported by low-cost Colombian cultivation, EU manufacturing capacity and expanding medical cannabis regulation, and investors may view its vertically integrated, GMP-focused platform as a route to global supply and contract opportunities.

Principal risks include regulatory and legal uncertainty across jurisdictions, competitive and pricing pressure, operational and cross-border manufacturing challenges, and limited liquidity and financing disclosure typical of OTC-listed cannabis companies.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
17.42M
Revenue Per Share
11.11
Gross Profit TTM
6.56M
Debt / Equity
0.09
ROE
-61.27%
Net Debt
-4.74M
ROCE
-77.39%
Diluted EPS TTM
-4.21

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -19.73M -72.45M -44.68M -36.67M -45.88M
Minority interest - - 0.00M - 4.70M
Net income -17.90M -66.10M -45.63M -41.41M -48.13M
Selling general administrative 17.99M 27.82M 38.40M 29.83M 34.98M
Selling and marketing expenses 2.04M 1.90M 3.80M 2.58M 3.18M
Gross profit 6.56M 4.33M 6.81M 7.41M 3.10M
Reconciled depreciation 3.02M 3.67M 3.51M 3.59M 1.48M
Ebit -19.68M -29.16M -38.70M -26.85M -36.54M
Ebitda -16.84M -25.69M -34.69M -24.71M -35.59M
Depreciation and amortization 2.85M 3.47M 4.01M 2.14M 0.95M
Non operating income net other - - - -7.10M -
Operating income -15.59M -29.16M -38.70M -26.85M -36.54M
Other operating expenses 33.01M 46.96M 54.07M 38.96M 44.37M
Interest expense 0.05M 2.70M 6.82M 4.46M 2.68M
Tax provision 0.30M -6.35M 0.95M 0.00M 0.00M
Net interest income -0.03M -2.70M -6.82M -4.46M -2.68M
Non recurring - - - 1.68M -
Income tax expense 0.07M -6.35M 0.95M 4.74M 2.25M
Total revenue 17.42M 17.80M 15.37M 12.12M 7.83M
Total operating expenses 22.15M 33.49M 45.51M 34.26M 39.64M
Cost of revenue 10.86M 13.47M 8.56M 4.70M 4.73M
Total other income expense net -4.13M -43.30M -5.98M -9.83M -9.34M
Net income from continuing ops -50.69M -66.17M -45.73M -36.67M -45.98M
Net income applicable to common shares - - -45.73M -36.11M -39.53M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 31.24M 52.10M 116.16M 165.88M 95.72M
Intangible assets 2.65M 3.35M 23.12M 24.28M 25.51M
Other current assets 0.55M 3.15M 0.47M 3.53M 4.44M
Total liab 7.03M 11.69M 43.39M 51.57M 45.52M
Total stockholder equity 24.22M 40.41M 72.77M 114.31M 45.50M
Deferred long term liab - - - 5.70M -
Other current liab 2.07M 4.35M 5.10M 4.87M 2.72M
Common stock - 3.36M - - -
Capital stock 0.00M 0.00M 0.00M 0.00M 0.00M
Retained earnings -198.80M -180.91M -114.74M -79.79M -31.93M
Other liab - - 8.56M 7.56M 5.70M
Good will - - 0.00M 18.51M 20.19M
Other assets 0.00M - 0.26M 0.05M 0.00M
Cash 6.83M 12.45M 37.23M 79.46M 12.04M
Total current liabilities 5.81M 9.43M 27.25M 10.16M 6.10M
Current deferred revenue 0.02M 1.07M 0.65M 0.87M -
Net debt -4.74M -8.59M -12.13M -45.62M 21.68M
Short term debt 1.27M 1.70M 17.51M - -
Short long term debt 0.50M 0.47M 17.51M - -
Short long term debt total 2.09M 3.86M 25.09M 33.84M 33.73M
Other stockholder equity 223.02M 217.95M 187.51M 194.10M 77.43M
Property plant equipment - - 30.93M 25.68M 24.37M
Total current assets 13.94M 26.25M 60.39M 95.81M 23.50M
Long term investments 0.00M 5.68M 1.46M 1.55M 2.08M
Net tangible assets - - 49.65M 52.46M -0.20M
Net receivables 2.08M 4.32M 7.29M 6.16M 1.60M
Long term debt 0.72M 1.06M 7.59M 33.84M 33.73M
Inventory 4.48M 8.40M 15.41M 10.19M 5.42M
Accounts payable 2.06M 2.30M 3.98M 4.43M 3.37M
Accumulated other comprehensive income 0.00M - - - -
Retained earnings total equity - - - -69.01M -
Non currrent assets other 1.50M 6.70M 0.26M 0.05M 0.07M
Non current assets total 17.30M 25.85M 55.77M 70.07M 72.22M
Capital lease obligations 0.87M 2.33M - - -
Long term debt total - - - 33.84M -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments 3.19M 1.19M -7.28M -3.67M -1.80M
Change to liabilities - - -4.20M 6.00M 3.79M
Total cashflows from investing activities 4.69M - -7.28M -3.67M -33.90M
Net borrowings -0.48M - 1.38M 6.54M 34.13M
Total cash from financing activities 0.66M 3.29M 1.83M 91.84M 62.83M
Change to operating activities - - -1.37M -0.11M -2.79M
Net income -19.80M -66.17M -45.73M -36.67M -45.98M
Change in cash -5.99M -24.81M -41.76M 66.26M -8.06M
Begin period cash flow 12.89M 37.70M 79.46M 13.20M 21.26M
End period cash flow 6.90M 12.89M 37.70M 79.46M 13.20M
Total cash from operating activities -11.51M -29.07M -36.23M -21.96M -37.05M
Issuance of capital stock 1.34M 27.69M 0.00M 18.02M 28.57M
Depreciation 2.85M 3.67M 3.51M 3.59M 1.48M
Other cashflows from investing activities 2.86M - - - -
Dividends paid - - - 10.75M -
Change to inventory 2.56M -4.45M -8.20M -4.77M -1.26M
Change to account receivables 1.40M -0.28M -0.55M -1.15M -0.53M
Sale purchase of stock - - 0.00M -6.25M 0.00M
Other cashflows from financing activities -0.20M -1.27M 28.37M 95.01M 34.88M
Change to netincome - - 16.07M 0.38M 1.79M
Capital expenditures 0.03M 1.31M 7.28M 3.67M 18.68M
Change receivables - - - -1.38M -
Cash flows other operating - - - 10.83M -
Cash and cash equivalents changes - - - 66.21M -
Change in working capital 0.14M -9.00M -14.31M -0.04M -0.79M
Stock based compensation 0.82M 2.34M 11.45M 1.65M 1.52M
Other non cash items 4.49M 46.73M 7.89M 3.85M 0.55M
Free cash flow -11.54M -30.37M -43.51M -25.63M -55.73M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CLVR
Clever Leaves Holdings Inc		 -
-%		 0.00 - - - - 0.21 -0.07
MKKGY
Merck KGaA ADR		 -0.22
0.66%		 33.17 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -2.76
1.62%		 167.12 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR		 -0.17
0.80%		 21.02 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.		 -
-%		 41.85 - 10.66 0.01 1.16 2.94 23.11

Profile*

Clever Leaves Holdings Inc

Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.

Bodega 19-B, Parque Ind. Tibitoc P.H, Tocancipá, Colombia, 251017

561 634 7430

https://cleverleaves.com

296

Name Title Year Born
Mr. Andres Fajardo Co-Founder, CEO & Director 1978
Mr. Henry R. Hague III Chief Financial Officer 1972
Mr. Gustavo Escobar Chief Operating Officer NA
Mr. David M. Kastin Esq. Gen. Counsel & Corp. Sec. 1968
Diana Sigüenza Strategic Communications Director NA
Mr. Amit Pandey Exec. VP of Fin. 1982
Mr. Julian Wilches Chief Regulatory Officer 1979
Mr. Andrew Miller Head of Bus. Devel. NA
Mr. Camilo Bohorquez Head of Colombia NA
Ms. Caroline Kliess Managing Director of Germany NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…